Seroepidemiology of hepatitis a in the croatian population
- PMID: 22368685
- PMCID: PMC3282034
- DOI: 10.5812/kowsar.1735143X.756
Seroepidemiology of hepatitis a in the croatian population
Abstract
Background: Hepatitis A virus (HAV) has a worldwide distribution, although this distribution tends to be uneven among geographical regions and population groups. The prevalence of anti-HAV antibodies in the general population varies widely among countries. In Europe, the seroprevalence of HAV is reported to range from 32% to 88%.
Objectives: The aim of this study was to determine the seroprevalence of HAV among the general Croatian population.
Materials and methods: During a 2-year period (2008-2009), a total of 791 serum samples were tested for the presence of anti-HAV total (IgM+IgG) and anti-HAV IgM antibodies using an automated enzyme-linked fluorescent assay (Mini Vidas; bioMérieux, Marcy l'Etoile, France).
Results: The overall anti-HAV seroprevalence was 41.6%. The observed difference in the seroprevalence rates among male and female patients was not statistically significant (44% vs. 39.6%, P = 0.218). A marked increase in anti-HAV seropositivity with age was observed (P < 0.001). The seroprevalence did not differ significantly between participants residing in rural regions (45.3%) and those residing in urban regions (40.6%, P = 0.292).
Conclusions: Our results corroborate those of seroprevalence studies in other developed countries. More than half of the Croatian population (59.4%) is susceptible to HAV infection. Older age is an important predictor for being anti-HAV positive.
Keywords: Croatia; Epidemiology; Hepatitis A Virus; Seroepidemiologic Studies.
Figures
References
-
- World Health Organization. Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec. 2000;75:38–44. - PubMed
-
- Hollinger FB, Emerson SU,Hepatitis A virus. Fields Virology. In: Knipe DM HP, Griffin DE, editors. Philadelphia: Lippincott Williams and Wilkins Publishers; 2001. pp. p799–840.
-
- Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995;171(Suppl 1):S2–8. - PubMed
-
- Tsega E, Nordenfelt E, Mengesha B, Hansson BG, Tsega M, Lindberg J. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis. 1990;22(2):145–8. - PubMed
-
- Ansaldi F, Bruzzone B, Rota MC, Bella A, Ciofi degli Atti M, Durando P, Gasparini R, Icardi G, Serologic Study Group. Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study. Eur J Epidemiol. 2008;23(1):45–53. - PubMed
LinkOut - more resources
Full Text Sources